Over the last two decades, the number of Americans with kidney cancer has risen each year.
The most common type of kidney cancer, renal cell carcinoma (RCC), generally affects people between 50 and 70 years of age.
With new treatment options available, those affected by advanced RCC have more reasons to feel hopeful. Dr. Saby George, who specializes in the treatment of kidney, bladder and prostate cancers and Dena Battle, President of KCCure, join us with more.
